Abacavir/Lamivudina Glenmark

Abacavir/Lamivudine Glenmark is a combination antiretroviral medication used to manage HIV infection. This oral treatment helps control the virus and improve immune function.

Abacavir/Lamivudine Glenmark is primarily used in the treatment of HIV infection. This combination therapy works by reducing the amount of HIV in the body, helping to slow the progression of the disease and improve immune function. It is often prescribed as part of a broader treatment plan to manage HIV.

Common effects of Abacavir/Lamivudine Glenmark may include headaches, nausea, and fatigue. Some individuals may experience more severe reactions, such as liver problems or allergic reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Abacavir/Lamivudine Glenmark should be used with caution in individuals with liver disease or a history of allergic reactions to similar medications. Regular monitoring of liver function and overall health is recommended. Always follow the advice of a healthcare professional regarding the use of this medication.

Abacavir/Lamivudine Glenmark may interact with other medications, including certain antiretrovirals and drugs that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Always inform your healthcare provider about all medications and supplements you are taking.